パニック発作治療の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE3930)
◆英語タイトル:Global Panic Attack Treatment Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE3930
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:108
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、パニック発作治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(選択的セロトニン再取り込み阻害薬(SSRI)、セロトニンノルエピネフリン再取り込み阻害薬(SNRI)、ベンゾジアゼピン(BZD))、用途別市場規模(病院、メンタルヘルスケアセンター、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・パニック発作治療の市場動向
・企業の競争状況、市場シェア
・パニック発作治療の種類別市場規模(選択的セロトニン再取り込み阻害薬(SSRI)、セロトニンノルエピネフリン再取り込み阻害薬(SNRI)、ベンゾジアゼピン(BZD))
・パニック発作治療の用途別市場規模(病院、メンタルヘルスケアセンター、その他)
・パニック発作治療の北米市場規模2016-2027(アメリカ、カナダ)
・パニック発作治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・パニック発作治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・パニック発作治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・パニック発作治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(GlaxoSmithKline plc.、F. Hoffmann-La Roche Ltd、Actavis Generics、Noven Pharmaceuticals, Inc.、Recordati Rare Diseases(Recordati)、Shionogi & Co., Ltd.、Abbott Laboratories、Sumitomo Dainippon Pharma、Pfizer,Inc.、Bristol Myers Squibb(BMS)、Baxter International Inc.、Eli Lilly and Company)
・結論
【レポートの概要】

Panic attacks are caused when patients feel with sudden surge of overwhelming anxiety and fear.

Market Analysis and Insights: Global Panic Attack Treatment Market
The global Panic Attack Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Panic Attack Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Panic Attack Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Panic Attack Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Panic Attack Treatment market.

Global Panic Attack Treatment Scope and Market Size
Panic Attack Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Panic Attack Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Selective Serotonin Reuptake Inhibitor(SSRI)
Serotonin Norepinephrine Reuptake Inhibitor(SNRI)
Benzodiazepines(BZD)

Segment by Application
Hospitals
Mental Healthcare Centers
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GlaxoSmithKline plc.
F. Hoffmann-La Roche Ltd
Actavis Generics
Noven Pharmaceuticals, Inc.
Recordati Rare Diseases(Recordati)
Shionogi & Co., Ltd.
Abbott Laboratories
Sumitomo Dainippon Pharma
Pfizer,Inc.
Bristol Myers Squibb(BMS)
Baxter International Inc.
Eli Lilly and Company

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Panic Attack Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Selective Serotonin Reuptake Inhibitor(SSRI)
1.2.3 Serotonin Norepinephrine Reuptake Inhibitor(SNRI)
1.2.4 Benzodiazepines(BZD)
1.3 Market by Application
1.3.1 Global Panic Attack Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Mental Healthcare Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Panic Attack Treatment Market Perspective (2016-2027)
2.2 Panic Attack Treatment Growth Trends by Regions
2.2.1 Panic Attack Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Panic Attack Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Panic Attack Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Panic Attack Treatment Industry Dynamic
2.3.1 Panic Attack Treatment Market Trends
2.3.2 Panic Attack Treatment Market Drivers
2.3.3 Panic Attack Treatment Market Challenges
2.3.4 Panic Attack Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Panic Attack Treatment Players by Revenue
3.1.1 Global Top Panic Attack Treatment Players by Revenue (2016-2021)
3.1.2 Global Panic Attack Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Panic Attack Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Panic Attack Treatment Revenue
3.4 Global Panic Attack Treatment Market Concentration Ratio
3.4.1 Global Panic Attack Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Panic Attack Treatment Revenue in 2020
3.5 Panic Attack Treatment Key Players Head office and Area Served
3.6 Key Players Panic Attack Treatment Product Solution and Service
3.7 Date of Enter into Panic Attack Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Panic Attack Treatment Breakdown Data by Type
4.1 Global Panic Attack Treatment Historic Market Size by Type (2016-2021)
4.2 Global Panic Attack Treatment Forecasted Market Size by Type (2022-2027)

5 Panic Attack Treatment Breakdown Data by Application
5.1 Global Panic Attack Treatment Historic Market Size by Application (2016-2021)
5.2 Global Panic Attack Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Panic Attack Treatment Market Size (2016-2027)
6.2 North America Panic Attack Treatment Market Size by Type
6.2.1 North America Panic Attack Treatment Market Size by Type (2016-2021)
6.2.2 North America Panic Attack Treatment Market Size by Type (2022-2027)
6.2.3 North America Panic Attack Treatment Market Size by Type (2016-2027)
6.3 North America Panic Attack Treatment Market Size by Application
6.3.1 North America Panic Attack Treatment Market Size by Application (2016-2021)
6.3.2 North America Panic Attack Treatment Market Size by Application (2022-2027)
6.3.3 North America Panic Attack Treatment Market Size by Application (2016-2027)
6.4 North America Panic Attack Treatment Market Size by Country
6.4.1 North America Panic Attack Treatment Market Size by Country (2016-2021)
6.4.2 North America Panic Attack Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Panic Attack Treatment Market Size (2016-2027)
7.2 Europe Panic Attack Treatment Market Size by Type
7.2.1 Europe Panic Attack Treatment Market Size by Type (2016-2021)
7.2.2 Europe Panic Attack Treatment Market Size by Type (2022-2027)
7.2.3 Europe Panic Attack Treatment Market Size by Type (2016-2027)
7.3 Europe Panic Attack Treatment Market Size by Application
7.3.1 Europe Panic Attack Treatment Market Size by Application (2016-2021)
7.3.2 Europe Panic Attack Treatment Market Size by Application (2022-2027)
7.3.3 Europe Panic Attack Treatment Market Size by Application (2016-2027)
7.4 Europe Panic Attack Treatment Market Size by Country
7.4.1 Europe Panic Attack Treatment Market Size by Country (2016-2021)
7.4.2 Europe Panic Attack Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Panic Attack Treatment Market Size (2016-2027)
8.2 Asia-Pacific Panic Attack Treatment Market Size by Type
8.2.1 Asia-Pacific Panic Attack Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Panic Attack Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Panic Attack Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Panic Attack Treatment Market Size by Application
8.3.1 Asia-Pacific Panic Attack Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Panic Attack Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Panic Attack Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Panic Attack Treatment Market Size by Region
8.4.1 Asia-Pacific Panic Attack Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Panic Attack Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Panic Attack Treatment Market Size (2016-2027)
9.2 Latin America Panic Attack Treatment Market Size by Type
9.2.1 Latin America Panic Attack Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Panic Attack Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Panic Attack Treatment Market Size by Type (2016-2027)
9.3 Latin America Panic Attack Treatment Market Size by Application
9.3.1 Latin America Panic Attack Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Panic Attack Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Panic Attack Treatment Market Size by Application (2016-2027)
9.4 Latin America Panic Attack Treatment Market Size by Country
9.4.1 Latin America Panic Attack Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Panic Attack Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Panic Attack Treatment Market Size (2016-2027)
10.2 Middle East & Africa Panic Attack Treatment Market Size by Type
10.2.1 Middle East & Africa Panic Attack Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Panic Attack Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Panic Attack Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Panic Attack Treatment Market Size by Application
10.3.1 Middle East & Africa Panic Attack Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Panic Attack Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Panic Attack Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Panic Attack Treatment Market Size by Country
10.4.1 Middle East & Africa Panic Attack Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Panic Attack Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GlaxoSmithKline plc.
11.1.1 GlaxoSmithKline plc. Company Details
11.1.2 GlaxoSmithKline plc. Business Overview
11.1.3 GlaxoSmithKline plc. Panic Attack Treatment Introduction
11.1.4 GlaxoSmithKline plc. Revenue in Panic Attack Treatment Business (2016-2021)
11.1.5 GlaxoSmithKline plc. Recent Development
11.2 F. Hoffmann-La Roche Ltd
11.2.1 F. Hoffmann-La Roche Ltd Company Details
11.2.2 F. Hoffmann-La Roche Ltd Business Overview
11.2.3 F. Hoffmann-La Roche Ltd Panic Attack Treatment Introduction
11.2.4 F. Hoffmann-La Roche Ltd Revenue in Panic Attack Treatment Business (2016-2021)
11.2.5 F. Hoffmann-La Roche Ltd Recent Development
11.3 Actavis Generics
11.3.1 Actavis Generics Company Details
11.3.2 Actavis Generics Business Overview
11.3.3 Actavis Generics Panic Attack Treatment Introduction
11.3.4 Actavis Generics Revenue in Panic Attack Treatment Business (2016-2021)
11.3.5 Actavis Generics Recent Development
11.4 Noven Pharmaceuticals, Inc.
11.4.1 Noven Pharmaceuticals, Inc. Company Details
11.4.2 Noven Pharmaceuticals, Inc. Business Overview
11.4.3 Noven Pharmaceuticals, Inc. Panic Attack Treatment Introduction
11.4.4 Noven Pharmaceuticals, Inc. Revenue in Panic Attack Treatment Business (2016-2021)
11.4.5 Noven Pharmaceuticals, Inc. Recent Development
11.5 Recordati Rare Diseases(Recordati)
11.5.1 Recordati Rare Diseases(Recordati) Company Details
11.5.2 Recordati Rare Diseases(Recordati) Business Overview
11.5.3 Recordati Rare Diseases(Recordati) Panic Attack Treatment Introduction
11.5.4 Recordati Rare Diseases(Recordati) Revenue in Panic Attack Treatment Business (2016-2021)
11.5.5 Recordati Rare Diseases(Recordati) Recent Development
11.6 Shionogi & Co., Ltd.
11.6.1 Shionogi & Co., Ltd. Company Details
11.6.2 Shionogi & Co., Ltd. Business Overview
11.6.3 Shionogi & Co., Ltd. Panic Attack Treatment Introduction
11.6.4 Shionogi & Co., Ltd. Revenue in Panic Attack Treatment Business (2016-2021)
11.6.5 Shionogi & Co., Ltd. Recent Development
11.7 Abbott Laboratories
11.7.1 Abbott Laboratories Company Details
11.7.2 Abbott Laboratories Business Overview
11.7.3 Abbott Laboratories Panic Attack Treatment Introduction
11.7.4 Abbott Laboratories Revenue in Panic Attack Treatment Business (2016-2021)
11.7.5 Abbott Laboratories Recent Development
11.8 Sumitomo Dainippon Pharma
11.8.1 Sumitomo Dainippon Pharma Company Details
11.8.2 Sumitomo Dainippon Pharma Business Overview
11.8.3 Sumitomo Dainippon Pharma Panic Attack Treatment Introduction
11.8.4 Sumitomo Dainippon Pharma Revenue in Panic Attack Treatment Business (2016-2021)
11.8.5 Sumitomo Dainippon Pharma Recent Development
11.9 Pfizer,Inc.
11.9.1 Pfizer,Inc. Company Details
11.9.2 Pfizer,Inc. Business Overview
11.9.3 Pfizer,Inc. Panic Attack Treatment Introduction
11.9.4 Pfizer,Inc. Revenue in Panic Attack Treatment Business (2016-2021)
11.9.5 Pfizer,Inc. Recent Development
11.10 Bristol Myers Squibb(BMS)
11.10.1 Bristol Myers Squibb(BMS) Company Details
11.10.2 Bristol Myers Squibb(BMS) Business Overview
11.10.3 Bristol Myers Squibb(BMS) Panic Attack Treatment Introduction
11.10.4 Bristol Myers Squibb(BMS) Revenue in Panic Attack Treatment Business (2016-2021)
11.10.5 Bristol Myers Squibb(BMS) Recent Development
11.11 Baxter International Inc.
11.11.1 Baxter International Inc. Company Details
11.11.2 Baxter International Inc. Business Overview
11.11.3 Baxter International Inc. Panic Attack Treatment Introduction
11.11.4 Baxter International Inc. Revenue in Panic Attack Treatment Business (2016-2021)
11.11.5 Baxter International Inc. Recent Development
11.12 Eli Lilly and Company
11.12.1 Eli Lilly and Company Company Details
11.12.2 Eli Lilly and Company Business Overview
11.12.3 Eli Lilly and Company Panic Attack Treatment Introduction
11.12.4 Eli Lilly and Company Revenue in Panic Attack Treatment Business (2016-2021)
11.12.5 Eli Lilly and Company Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ パニック発作治療の世界市場規模・現状・予測2021年-2027年(Global Panic Attack Treatment Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。